author-photo

Reshma A. Rangwala

Princeton University

7

Papers

68

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer.

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (12)
424 A phase 1b/2 randomized study of AVB-S6–500 in combination with cabozantinib versus cabozantinib alone in patients with advanced clear cell renal cell carcinoma who have received front-line treatment

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (46)
Phase 2 trial of tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)